1,106 results on '"Amin, Mahul B."'
Search Results
2. Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
3. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
4. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
5. Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
6. Predicting Prostate Cancer-Specific Mortality with A.I.-based Gleason Grading
7. Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
8. Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions
9. Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis
10. Flat intraurothelial lesions of the urinary bladder—do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice
11. Similar Image Search for Histopathology: SMILY
12. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
13. Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia
14. Development and Validation of a Deep Learning Algorithm for Improving Gleason Scoring of Prostate Cancer
15. Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes
16. Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies
17. Current best practice for bladder cancer: a narrative review of diagnostics and treatments
18. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
19. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
20. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521
21. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415
22. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)
23. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases
24. Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
25. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
26. A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022)
27. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
28. Response to the Letter to the Editor Entitled “Do We Have Sufficient Evidence to Define Prognosis for ‘Low-Grade’ Fumarate Hydratase-Deficient Renal Cell Carcinoma?”
29. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial
30. Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
31. Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading
32. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile
33. Comparaison des classifications TNM des 8es éditions de l’UICC et de l’AJCC en uropathologie
34. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors
35. Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes
36. Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
37. Smoothelin expression in the gastrointestinal tract: implication in colonic inertia.
38. Penis and Scrotum
39. Contributors
40. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra
41. Pathologic Assessment and Implications Following Focal Therapy of Prostate Cancer
42. Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study
43. Histologic Validation of 11Carbon-Acetate Positron Emission Tomography/Computer Tomography in Detecting Lymph Node Metastases in Prostate Cancer
44. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists
45. Surveillance after prostate focal therapy
46. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists
47. mtDNA Mutations Increase Tumorigenicity in Prostate Cancer
48. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification
49. Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions
50. Pericytic tumors of the kidney—a clinicopathologic analysis of 17 cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.